Notice Information
Notice Title
NHS Framework Agreement, Branded Medicines for London and South of England
Notice Description
NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure (above threshold)
- Tender Suitability
- SME
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £441,994,547 £100M-£1B
- Lots Value
- Not specified
- Awards Value
- £558,521,926 £100M-£1B
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 17 Sep 20214 years ago
- Submission Deadline
- 4 Jun 2021Expired
- Future Notice Date
- Not specified
- Award Date
- 18 Aug 20214 years ago
- Contract Period
- 31 Aug 2021 - 31 Aug 2023 1-2 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Not Specified
- Awards Status
- Active
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- RUNCORN
- Postcode
- WA7 2ES
- Post Town
- Warrington
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD7 Merseyside
- Small Region (ITL 3)
- TLD71 East Merseyside
- Delivery Location
- TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
-
- Local Authority
- Halton
- Electoral Ward
- Halton Lea
- Westminster Constituency
- Runcorn and Helsby
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d
17th September 2021 - Awarded contract notice on Contracts Finder -
https://www.contractsfinder.service.gov.uk/Notice/87462943-eaf5-48e4-8e64-f87426d9c24c
17th September 2021 - Awarded contract notice on Contracts Finder -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj4/e4859nDqBoSEEAiTSAYCf.h8.XseZEZGtK.tS1W6BIk
Parties Awarded to Framework -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVio/gHNH8g8.YgKa2hmBgMeIkTCt98GDQwZSf8Q0we4OOHw
03. Framework Agreement and Terms and Conditions -CM_PHR_20_5598 NHS Framework Agreement, Branded Medicines for London and South of England Template -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj3/F2uf5OXU_ZCY1h0I.EL_RTPdm8OpkPOaQdyba99QRrQ
CM_PHR_20_5598_01 - NHS Framework LONDON Branded Medicines - Tranche B Transparency Award Schedule -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVit/WA7wOa57AKOMfFmG37.jte257TrDW38H._iXppUJOmE
CM_PHR_20_5598_06 - NHS Framework Midlands & East and NofE - Bevacizumab Transparency Award Schedule -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj2/no32CQoP7LDSZpTThhQmRG6N4LWIyECrHCy24M95qkE
CM _PHR_20_5598_03 - NHS Framework SOUTH of England Tranche A Transparency Award Schedule -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVis/kL0N6R5GgfobI40X.C2zFegh6.2h6aF.ZKMLfZxAvtk
CM_PHR_20_5598_04- NHS Framework SOUTH of England - Tranche B. Transparency Award Schedule -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVix/_0ogC52eXQSjNBdxTY5Jir5zL8U9vtCjHx4oppSM6x0
CM_PHR_20_5598_02 - NHS Framework LONDON Branded Medicines - Annual Tranche Transparency Award Schedule -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVin/epK1hXNyTh5O9gdN.Fkye6ESV54MJt_kgK5srRD4EyM
CM_PHR_20_5598_05 - NHS Framework SOUTH of England Annual Tranche Transparency Award Schedule
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b-2021-09-17T16:11:33+01:00",
"date": "2021-09-17T16:11:33+01:00",
"ocid": "ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b",
"language": "en",
"initiationType": "tender",
"tender": {
"id": "CF-0345200D0O000000rwimUAA2",
"title": "NHS Framework Agreement, Branded Medicines for London and South of England",
"description": "NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"postalCode": "WA7 2ES"
},
{
"region": "East Midlands",
"countryName": "United Kingdom"
},
{
"region": "East of England",
"countryName": "United Kingdom"
},
{
"region": "London",
"countryName": "United Kingdom"
},
{
"region": "North East",
"countryName": "United Kingdom"
},
{
"region": "North West",
"countryName": "United Kingdom"
},
{
"region": "South East",
"countryName": "United Kingdom"
},
{
"region": "South West",
"countryName": "United Kingdom"
},
{
"region": "West Midlands",
"countryName": "United Kingdom"
},
{
"region": "Yorkshire and the Humber",
"countryName": "United Kingdom"
},
{
"countryName": "Isle of Man"
},
{
"postalCode": "WA7 2ES"
},
{
"region": "East Midlands",
"countryName": "United Kingdom"
},
{
"region": "East of England",
"countryName": "United Kingdom"
},
{
"region": "London",
"countryName": "United Kingdom"
},
{
"region": "North East",
"countryName": "United Kingdom"
},
{
"region": "North West",
"countryName": "United Kingdom"
},
{
"region": "South East",
"countryName": "United Kingdom"
},
{
"region": "South West",
"countryName": "United Kingdom"
},
{
"region": "West Midlands",
"countryName": "United Kingdom"
},
{
"region": "Yorkshire and the Humber",
"countryName": "United Kingdom"
},
{
"countryName": "Isle of Man"
}
]
}
],
"value": {
"amount": 441994547,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure (above threshold)",
"tenderPeriod": {
"endDate": "2021-06-04T13:00:00+01:00"
},
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2023-08-31T23:59:59+01:00"
},
"suitability": {
"sme": true,
"vcse": false
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-CFS-156204",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "2nd Floor, Rutland House",
"locality": "Runcorn",
"postalCode": "WA7 2ES",
"countryName": "GB"
},
"contactPoint": {
"name": "Giorgie Rushton",
"email": "giorgie.rushton2@nhs.net"
},
"roles": [
"buyer"
]
},
{
"id": "GB-CFS-165040",
"name": "Dr.Reddy's Laboratories (UK) Limited",
"identifier": {
"legalName": "Dr.Reddy's Laboratories (UK) Limited"
},
"address": {
"streetAddress": ", Beverley"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183727",
"name": "Accord-UK Ltd",
"identifier": {
"legalName": "Accord-UK Ltd"
},
"address": {
"streetAddress": ", Devon"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183728",
"name": "Techdow Pharma England Ltd",
"identifier": {
"legalName": "Techdow Pharma England Ltd"
},
"address": {
"streetAddress": ", Guildford"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma",
"identifier": {
"legalName": "UL Global Pharma"
},
"address": {
"streetAddress": ", Hertfordshire"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183730",
"name": "Biogen",
"identifier": {
"legalName": "Biogen"
},
"address": {
"streetAddress": ", Maidenhead"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183731",
"name": "Amgen Ltd",
"identifier": {
"legalName": "Amgen Ltd"
},
"address": {
"streetAddress": ", Cambridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd",
"identifier": {
"legalName": "Thornton and Ross Ltd"
},
"address": {
"streetAddress": ", Huddersfield"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183732",
"name": "Merck Sharpe & Dohme (UK) Limited",
"identifier": {
"legalName": "Merck Sharpe & Dohme (UK) Limited"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183733",
"name": "Bayer Ltd",
"identifier": {
"legalName": "Bayer Ltd"
},
"address": {
"streetAddress": ", Reading"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd",
"identifier": {
"legalName": "Zentiva Pharma UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183734",
"name": "Napp Pharmaceuticals Ltd",
"identifier": {
"legalName": "Napp Pharmaceuticals Ltd"
},
"address": {
"streetAddress": ", Cambridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183735",
"name": "Novo Nordisk",
"identifier": {
"legalName": "Novo Nordisk"
},
"address": {
"streetAddress": ", Gatwick"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183736",
"name": "Daiichi Sankyo UK Ltd",
"identifier": {
"legalName": "Daiichi Sankyo UK Ltd"
},
"address": {
"streetAddress": ", Uxbridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183737",
"name": "Gedeon Richter UK Ltd",
"identifier": {
"legalName": "Gedeon Richter UK Ltd"
},
"address": {
"streetAddress": ", Maida Vale"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited",
"identifier": {
"legalName": "Teva UK Limited"
},
"address": {
"streetAddress": ", Castleford"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183738",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": ", Kent"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183739",
"name": "Roche Products Ltd",
"identifier": {
"legalName": "Roche Products Ltd"
},
"address": {
"streetAddress": ", Garden City"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-165041",
"name": "Janssen-Cilag Ltd",
"identifier": {
"legalName": "Janssen-Cilag Ltd"
},
"address": {
"streetAddress": ", High Wycombe"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183740",
"name": "Mylan",
"identifier": {
"legalName": "Mylan"
},
"address": {
"streetAddress": ", Barnet"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183741",
"name": "Allergan",
"identifier": {
"legalName": "Allergan"
},
"address": {
"streetAddress": ", Marlow"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183742",
"name": "Organon Pharmaceuticals UK Ltd",
"identifier": {
"legalName": "Organon Pharmaceuticals UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"streetAddress": ", Camberley"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183743",
"name": "Celltrion Healthcare United Kingdom Limited",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"address": {
"streetAddress": ", Slough"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)",
"identifier": {
"legalName": "Sobi (Swedish Orphan Biovitrum Ltd)"
},
"address": {
"streetAddress": ", Cambridgeshire"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183745",
"name": "Merck Serono Limited",
"identifier": {
"legalName": "Merck Serono Limited"
},
"address": {
"streetAddress": ", Feltham"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183746",
"name": "Bristol Myers Squibb",
"identifier": {
"legalName": "Bristol Myers Squibb"
},
"address": {
"streetAddress": ", Uxbridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183747",
"name": "Eli Lilly & Company Ltd",
"identifier": {
"legalName": "Eli Lilly & Company Ltd"
},
"address": {
"streetAddress": ", Basingstoke"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183748",
"name": "Vifor Pharma UK Ltd",
"identifier": {
"legalName": "Vifor Pharma UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183749",
"name": "Merz",
"identifier": {
"legalName": "Merz"
},
"address": {
"streetAddress": ", Hemel Hempstead"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd",
"identifier": {
"legalName": "Takeda UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-165038",
"name": "AstraZeneca",
"identifier": {
"legalName": "AstraZeneca"
},
"address": {
"streetAddress": ", Luton"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183751",
"name": "Ferring Pharmaceuticals Ltd",
"identifier": {
"legalName": "Ferring Pharmaceuticals Ltd"
},
"address": {
"streetAddress": ", West Drayton"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183752",
"name": "Aventis Pharma ltd t/a Sanofi",
"identifier": {
"legalName": "Aventis Pharma ltd t/a Sanofi"
},
"address": {
"streetAddress": ", Reading"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183753",
"name": "Pharmacosmos UK Ltd",
"identifier": {
"legalName": "Pharmacosmos UK Ltd"
},
"address": {
"streetAddress": ", Reading"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183754",
"name": "Tetris Pharma Lts",
"identifier": {
"legalName": "Tetris Pharma Lts"
},
"address": {
"streetAddress": ", Northampton"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183755",
"name": "Ipsen",
"identifier": {
"legalName": "Ipsen"
},
"address": {
"streetAddress": ", Slough"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183756",
"name": "Profile Pharma Ltd",
"identifier": {
"legalName": "Profile Pharma Ltd"
},
"address": {
"streetAddress": ", Chichester"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183757",
"name": "CST Pharma Limited",
"identifier": {
"legalName": "CST Pharma Limited"
},
"address": {
"streetAddress": ", Walsall"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183758",
"name": "Gilead Sciences Limited",
"identifier": {
"legalName": "Gilead Sciences Limited"
},
"address": {
"streetAddress": ", Holborn"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
},
{
"id": "GB-CFS-183759",
"name": "Morningside Pharmaeuticals",
"identifier": {
"legalName": "Morningside Pharmaeuticals"
},
"address": {
"streetAddress": ", Northampton"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183760",
"name": "Chugai",
"identifier": {
"legalName": "Chugai"
},
"address": {
"streetAddress": ", Chiswick"
},
"details": {
"scale": "sme",
"vcse": false
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183761",
"name": "UCB",
"identifier": {
"legalName": "UCB"
},
"address": {
"streetAddress": ", Slough"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"vcse": false
}
}
],
"buyer": {
"id": "GB-CFS-156204",
"name": "NHS England"
},
"awards": [
{
"id": "ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b-1",
"status": "active",
"date": "2021-08-19T00:00:00+01:00",
"datePublished": "2021-09-17T16:08:15+01:00",
"value": {
"amount": 558521926,
"currency": "GBP"
},
"suppliers": [
{
"id": "GB-CFS-165040",
"name": "Dr.Reddy's Laboratories (UK) Limited"
},
{
"id": "GB-CFS-183727",
"name": "Accord-UK Ltd"
},
{
"id": "GB-CFS-183728",
"name": "Techdow Pharma England Ltd"
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma"
},
{
"id": "GB-CFS-183730",
"name": "Biogen"
},
{
"id": "GB-CFS-183731",
"name": "Amgen Ltd"
},
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd"
},
{
"id": "GB-CFS-183732",
"name": "Merck Sharpe & Dohme (UK) Limited"
},
{
"id": "GB-CFS-183733",
"name": "Bayer Ltd"
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd"
},
{
"id": "GB-CFS-183734",
"name": "Napp Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-183735",
"name": "Novo Nordisk"
},
{
"id": "GB-CFS-183736",
"name": "Daiichi Sankyo UK Ltd"
},
{
"id": "GB-CFS-183737",
"name": "Gedeon Richter UK Ltd"
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited"
},
{
"id": "GB-CFS-183738",
"name": "Pfizer Ltd"
},
{
"id": "GB-CFS-183739",
"name": "Roche Products Ltd"
},
{
"id": "GB-CFS-165041",
"name": "Janssen-Cilag Ltd"
},
{
"id": "GB-CFS-183740",
"name": "Mylan"
},
{
"id": "GB-CFS-183741",
"name": "Allergan"
},
{
"id": "GB-CFS-183742",
"name": "Organon Pharmaceuticals UK Ltd"
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd"
},
{
"id": "GB-CFS-183743",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
},
{
"id": "GB-CFS-183745",
"name": "Merck Serono Limited"
},
{
"id": "GB-CFS-183746",
"name": "Bristol Myers Squibb"
},
{
"id": "GB-CFS-183747",
"name": "Eli Lilly & Company Ltd"
},
{
"id": "GB-CFS-183748",
"name": "Vifor Pharma UK Ltd"
},
{
"id": "GB-CFS-183749",
"name": "Merz"
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd"
},
{
"id": "GB-CFS-165038",
"name": "AstraZeneca"
},
{
"id": "GB-CFS-183751",
"name": "Ferring Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-183752",
"name": "Aventis Pharma ltd t/a Sanofi"
},
{
"id": "GB-CFS-183753",
"name": "Pharmacosmos UK Ltd"
},
{
"id": "GB-CFS-183754",
"name": "Tetris Pharma Lts"
},
{
"id": "GB-CFS-183755",
"name": "Ipsen"
},
{
"id": "GB-CFS-183756",
"name": "Profile Pharma Ltd"
},
{
"id": "GB-CFS-183757",
"name": "CST Pharma Limited"
},
{
"id": "GB-CFS-183758",
"name": "Gilead Sciences Limited"
},
{
"id": "GB-CFS-183759",
"name": "Morningside Pharmaeuticals"
},
{
"id": "GB-CFS-183760",
"name": "Chugai"
},
{
"id": "GB-CFS-183761",
"name": "UCB"
}
],
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2023-08-31T23:59:59+01:00"
},
"documents": [
{
"id": "1",
"documentType": "awardNotice",
"description": "Awarded contract notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/87462943-eaf5-48e4-8e64-f87426d9c24c",
"datePublished": "2021-09-17T16:08:15+01:00",
"format": "text/html",
"language": "en"
}
]
},
{
"id": "ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b-2",
"status": "active",
"date": "2021-08-19T00:00:00+01:00",
"datePublished": "2021-09-17T16:11:33+01:00",
"value": {
"amount": 558521926,
"currency": "GBP"
},
"suppliers": [
{
"id": "GB-CFS-165040",
"name": "Dr.Reddy's Laboratories (UK) Limited"
},
{
"id": "GB-CFS-183727",
"name": "Accord-UK Ltd"
},
{
"id": "GB-CFS-183728",
"name": "Techdow Pharma England Ltd"
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma"
},
{
"id": "GB-CFS-183730",
"name": "Biogen"
},
{
"id": "GB-CFS-183731",
"name": "Amgen Ltd"
},
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd"
},
{
"id": "GB-CFS-183732",
"name": "Merck Sharpe & Dohme (UK) Limited"
},
{
"id": "GB-CFS-183733",
"name": "Bayer Ltd"
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd"
},
{
"id": "GB-CFS-183734",
"name": "Napp Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-183735",
"name": "Novo Nordisk"
},
{
"id": "GB-CFS-183736",
"name": "Daiichi Sankyo UK Ltd"
},
{
"id": "GB-CFS-183737",
"name": "Gedeon Richter UK Ltd"
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited"
},
{
"id": "GB-CFS-183738",
"name": "Pfizer Ltd"
},
{
"id": "GB-CFS-183739",
"name": "Roche Products Ltd"
},
{
"id": "GB-CFS-165041",
"name": "Janssen-Cilag Ltd"
},
{
"id": "GB-CFS-183740",
"name": "Mylan"
},
{
"id": "GB-CFS-183741",
"name": "Allergan"
},
{
"id": "GB-CFS-183742",
"name": "Organon Pharmaceuticals UK Ltd"
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd"
},
{
"id": "GB-CFS-183743",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
},
{
"id": "GB-CFS-183745",
"name": "Merck Serono Limited"
},
{
"id": "GB-CFS-183746",
"name": "Bristol Myers Squibb"
},
{
"id": "GB-CFS-183747",
"name": "Eli Lilly & Company Ltd"
},
{
"id": "GB-CFS-183748",
"name": "Vifor Pharma UK Ltd"
},
{
"id": "GB-CFS-183749",
"name": "Merz"
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd"
},
{
"id": "GB-CFS-165038",
"name": "AstraZeneca"
},
{
"id": "GB-CFS-183751",
"name": "Ferring Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-183752",
"name": "Aventis Pharma ltd t/a Sanofi"
},
{
"id": "GB-CFS-183753",
"name": "Pharmacosmos UK Ltd"
},
{
"id": "GB-CFS-183754",
"name": "Tetris Pharma Lts"
},
{
"id": "GB-CFS-183755",
"name": "Ipsen"
},
{
"id": "GB-CFS-183756",
"name": "Profile Pharma Ltd"
},
{
"id": "GB-CFS-183757",
"name": "CST Pharma Limited"
},
{
"id": "GB-CFS-183758",
"name": "Gilead Sciences Limited"
},
{
"id": "GB-CFS-183759",
"name": "Morningside Pharmaeuticals"
},
{
"id": "GB-CFS-183760",
"name": "Chugai"
},
{
"id": "GB-CFS-183761",
"name": "UCB"
}
],
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2023-08-31T23:59:59+01:00"
},
"documents": [
{
"id": "2",
"documentType": "awardNotice",
"description": "Awarded contract notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d",
"datePublished": "2021-09-17T16:11:33+01:00",
"format": "text/html",
"language": "en"
},
{
"id": "3",
"documentType": "Link",
"description": "Parties Awarded to Framework",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj4/e4859nDqBoSEEAiTSAYCf.h8.XseZEZGtK.tS1W6BIk"
},
{
"id": "4",
"documentType": "Link",
"description": "03. Framework Agreement and Terms and Conditions -CM_PHR_20_5598 NHS Framework Agreement, Branded Medicines for London and South of England Template",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVio/gHNH8g8.YgKa2hmBgMeIkTCt98GDQwZSf8Q0we4OOHw"
},
{
"id": "5",
"documentType": "Link",
"description": "CM_PHR_20_5598_01 - NHS Framework LONDON Branded Medicines - Tranche B Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj3/F2uf5OXU_ZCY1h0I.EL_RTPdm8OpkPOaQdyba99QRrQ"
},
{
"id": "6",
"documentType": "Link",
"description": "CM_PHR_20_5598_06 - NHS Framework Midlands & East and NofE - Bevacizumab Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVit/WA7wOa57AKOMfFmG37.jte257TrDW38H._iXppUJOmE"
},
{
"id": "7",
"documentType": "Link",
"description": "CM _PHR_20_5598_03 - NHS Framework SOUTH of England Tranche A Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVj2/no32CQoP7LDSZpTThhQmRG6N4LWIyECrHCy24M95qkE"
},
{
"id": "8",
"documentType": "Link",
"description": "CM_PHR_20_5598_04- NHS Framework SOUTH of England - Tranche B. Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVis/kL0N6R5GgfobI40X.C2zFegh6.2h6aF.ZKMLfZxAvtk"
},
{
"id": "9",
"documentType": "Link",
"description": "CM_PHR_20_5598_02 - NHS Framework LONDON Branded Medicines - Annual Tranche Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVix/_0ogC52eXQSjNBdxTY5Jir5zL8U9vtCjHx4oppSM6x0"
},
{
"id": "10",
"documentType": "Link",
"description": "CM_PHR_20_5598_05 - NHS Framework SOUTH of England Annual Tranche Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000NVin/epK1hXNyTh5O9gdN.Fkye6ESV54MJt_kgK5srRD4EyM"
}
]
}
]
}